OTCMKTS:CMXC Cell MedX (CMXC) Stock Price, News & Analysis → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free CMXC Stock Alerts $0.04 -0.01 (-21.28%) (As of 04/22/2024 ET) Add Compare Share Share Today's Range$0.04▼$0.0450-Day Range$0.02▼$0.0552-Week Range$0.00▼$0.93Volume39,279 shsAverage Volume23,918 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get Cell MedX alerts: Email Address Ad Crypto 101 Media[Shocking] Elon Musk’s Plan To End BanksLeaked Elon Musk call reveals shocking plan to replace banks. As Musk's plan rolls out, industry experts predict it could spark a wave of mass crypto adoption. Triggering a new crypto bull run. While helping drive a booming crypto asset class up from $2.5-billion to $16-trillion (a 6,400x increase) by 2030. Click here now to get your copy. About Cell MedX Stock (OTCMKTS:CMXC)Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is headquartered in Carson City, Nevada.Read More CMXC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CMXC Stock News HeadlinesApril 2, 2024 | businessinsider.comThe best cell phone plans in 2024March 29, 2024 | bbc.co.ukCells, organ systems and ecosystemsApril 23, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.March 29, 2024 | seekingalpha.comCMXC Cell MedX Corp.February 14, 2024 | bbc.co.ukCell structure - AQA MicroscopesFebruary 14, 2024 | bbc.co.ukCell biologyJanuary 10, 2024 | morningstar.comCell MedX Corp CMXCDecember 19, 2023 | finance.yahoo.comCell MedX Corp. Announces New CEO and Directors and Debt SettlementApril 23, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.November 27, 2023 | finance.yahoo.comCell MedX Corp. Announces Full Revocation of British Columbia Cease Trade OrderNovember 9, 2023 | msn.comCell MedX says COO Costa resigns from the roleNovember 9, 2023 | finance.yahoo.comCell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating OfficerNovember 2, 2023 | businessinsider.comThe best cheap cell phone plans in 2023September 21, 2023 | bbc.co.ukCells of the nervous system, neurotransmitters at synapsesSeptember 11, 2023 | bbc.co.ukChemical cellsSeptember 11, 2023 | bbc.co.ukChemical cells and fuel cellsSeptember 10, 2023 | bbc.co.ukThe cell membraneApril 27, 2023 | bbc.co.ukMitosis and the cell cycleMarch 28, 2023 | bbc.co.ukDivision and differentiation in human cellsFebruary 11, 2023 | bbc.co.ukCells and ReproductionOctober 9, 2022 | usnews.comBest Cell Phone Plans of 2022October 2, 2022 | yahoo.com3 Different Types of Fat Cells and How to Lose ThemSeptember 20, 2022 | finance.yahoo.comFDA Submission and Corporate UpdateJune 27, 2022 | finance.yahoo.comCell MedX Corp: Letter to Shareholders from Mr. Dwayne Yaretz, CEOApril 27, 2022 | seekingalpha.comCell MedX names new CEOApril 27, 2022 | finance.yahoo.comCell MedX Corp. Appoints Mr. Dwayne Yaretz as CEO and DirectorMarch 24, 2022 | finance.yahoo.comCell MedX Corp. to Attend the 29th Annual Wellness Show 2022 Held in Vancouver, BCSee More Headlines Receive CMXC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cell MedX and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:CMXC Previous SymbolNASDAQ:CMXC CUSIPN/A CIK1493712 Webcellmedx.com Phone(844) 238-2692FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMs. Yanika Silina C.M.A. (Age 46)CPA, CFO, Treasurer, Corporate Secretary & Director Comp: $30kMr. David M. Jeffs (Age 54)President, CEO & Director Key CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXCellaVision AB (publ)OTCMKTS:CLVSFView All Competitors CMXC Stock Analysis - Frequently Asked Questions How have CMXC shares performed in 2024? Cell MedX's stock was trading at $0.0220 at the start of the year. Since then, CMXC shares have increased by 68.2% and is now trading at $0.0370. View the best growth stocks for 2024 here. What other stocks do shareholders of Cell MedX own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cell MedX investors own include Callon Petroleum (CPE), Himax Technologies (HIMX), Remark (MARK), MicroVision (MVIS), Ritter Pharmaceuticals (RTTR), Linn Energy (LINEQ), AudioEye (AEYE), Bank of America (BAC) and Celldex Therapeutics (CLDX). How do I buy shares of Cell MedX? Shares of CMXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CMXC) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cell MedX Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
